Oxford Nanopore Technologies plc (ONTTF)
USD 1.8
(-7.69%)
USD 1.8
(-7.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 259.09 Million GBP | 16.56% |
| 2022 | 222.28 Million GBP | -6.49% |
| 2021 | 237.72 Million GBP | 98.21% |
| 2020 | 119.93 Million GBP | 12.61% |
| 2019 | 106.51 Million GBP | 36.22% |
| 2018 | 78.19 Million GBP | 6.95% |
| 2017 | 73.11 Million GBP | 10.79% |
| 2016 | 65.98 Million GBP | 48.29% |
| 2015 | 44.5 Million GBP | 5.65% |
| 2014 | 42.12 Million GBP | 45.29% |
| 2013 | 28.99 Million GBP | 22.75% |
| 2012 | 23.61 Million GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 126.48 Million GBP | 0.0% |
| 2023 Q2 | 124.33 Million GBP | 103.36% |
| 2023 Q3 | 67.31 Million GBP | -45.86% |
| 2023 Q4 | 134.75 Million GBP | 100.21% |
| 2023 FY | 259.08 Million GBP | 16.56% |
| 2023 Q1 | 61.13 Million GBP | -49.63% |
| 2022 Q4 | 121.37 Million GBP | 129.57% |
| 2022 Q1 | 52.89 Million GBP | -67.74% |
| 2022 Q2 | 63.02 Million GBP | 19.14% |
| 2022 Q3 | 52.86 Million GBP | -16.11% |
| 2022 FY | 222.28 Million GBP | -6.49% |
| 2021 Q1 | 37.09 Million GBP | -40.29% |
| 2021 FY | 237.72 Million GBP | 98.21% |
| 2021 Q4 | 163.95 Million GBP | 99.55% |
| 2021 Q2 | 73.77 Million GBP | 98.87% |
| 2021 Q3 | 82.16 Million GBP | 11.37% |
| 2020 Q4 | 62.12 Million GBP | 103.69% |
| 2020 Q1 | 29.18 Million GBP | 0.0% |
| 2020 Q2 | 57.81 Million GBP | 98.07% |
| 2020 Q3 | 30.5 Million GBP | -47.24% |
| 2020 FY | 119.93 Million GBP | 12.61% |
| 2019 FY | 106.51 Million GBP | 36.22% |
| 2018 FY | 78.19 Million GBP | 6.95% |
| 2017 FY | 73.11 Million GBP | 10.79% |
| 2016 FY | 65.98 Million GBP | 48.29% |
| 2015 FY | 44.5 Million GBP | 5.65% |
| 2014 FY | 42.12 Million GBP | 45.29% |
| 2013 FY | 28.99 Million GBP | 22.75% |
| 2012 FY | 23.61 Million GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -198.542% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -5168.292% |
| SQZ Biotechnologies Company | 85.61 Million USD | -202.608% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -776.696% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -595.438% |
| Mesoblast Limited | 5.9 Million USD | -4289.868% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -17150.827% |
| Genus plc | 147.7 Million USD | -75.416% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -2851.169% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -19212.807% |
| Marizyme, Inc. | 19.23 Million USD | -1246.633% |
| ContraFect Corporation | 56.88 Million USD | -355.431% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -3006.967% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -5776.826% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -17420.855% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -8784.401% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -9185.192% |
| MultiCell Technologies, Inc. | 567.42 USD | -45660962.352% |
| Accustem Sciences Inc. | 3.74 Million USD | -6815.671% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -201.46% |
| EV Biologics, Inc. | 531.96 Thousand USD | -48604.607% |
| Q BioMed Inc. | 3.43 Million USD | -7439.076% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -948.311% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -66407.344% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -9760.622% |
| Biomind Labs Inc. | 994.18 Thousand USD | -25960.621% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | -14.9% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -3756.645% |
| Skye Bioscience, Inc. | 13.54 Million USD | -1812.449% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -12546.525% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 1036460.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -5038.591% |
| IMV Inc. | 37.7 Million USD | -587.073% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -1518.277% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -14018.615% |
| GB Sciences, Inc. | 1.42 Million USD | -18139.237% |
| Alpha Cognition Inc. | 9.7 Million USD | -2569.49% |
| HST Global, Inc. | 140.9 Thousand USD | -183773.051% |
| CSL Limited | 3.44 Billion USD | 92.488% |
| Halberd Corporation | 74.84 Thousand USD | -346082.625% |
| Enzolytics Inc. | 2.17 Million USD | -11787.551% |
| Resverlogix Corp. | 12.71 Million USD | -1938.153% |
| Affymax, Inc. | 39.38 Million USD | -557.823% |
| SYBLEU INC | 160.87 Thousand USD | -160949.504% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -6996.981% |
| argenx SE | 1.53 Billion USD | 83.105% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -351.062% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -24717.05% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -16304.798% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -7509.151% |
| AVAX Technologies, Inc. | 7.31 Million USD | -3444.195% |
| Zenith Capital Corp. | 8.94 Million USD | -2797.126% |
| Genscript Biotech Corporation | 825.34 Million USD | 68.608% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -1487128.058% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -10452.202% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -150964.959% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -160.837% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -14623.716% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -13038.212% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -13796.92% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -2284.191% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -13387.906% |
| BioStem Technologies, Inc. | 22.97 Million USD | -1027.714% |
| ONE Bio Corp. | 6.44 Million USD | -3920.707% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -142661.11% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -19301.227% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -22932.065% |
| Agentix Corp. | 1.37 Million USD | -18787.47% |
| LadRx Corporation | 3.81 Million USD | -6697.067% |
| Cell Source, Inc. | 4.32 Million USD | -5890.041% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -62259.349% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -27954.921% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -27954.921% |
| NovAccess Global Inc. | 2.46 Million USD | -10403.247% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -10673.269% |
| Itoco Inc. | 919.14 Thousand USD | -28088.214% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -6012.9% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -23053.709% |
| Kadimastem Ltd | 2.41 Million USD | -10650.123% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -98892.84% |
| CytoDyn Inc. | 18.05 Million USD | -1334.766% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -1029301.248% |
| Mobile Lads Corp. | 554.54 Thousand USD | -46621.102% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -117626.442% |
| Qrons Inc. | 643.67 Thousand USD | -40151.555% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -18148.448% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -11519.016% |
| Rebus Holdings, Inc. | 664 Thousand USD | -38919.578% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -14164.557% |
| International Stem Cell Corporation | 5.27 Million USD | -4815.386% |
| Bioxytran, Inc. | 3.82 Million USD | -6682.2% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -492073.55% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -1273507.629% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -614.416% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -15912.979% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -35110.339% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -8228.19% |
| Neutra Corp. | 243.82 Thousand USD | -106162.381% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -1384.161% |
| PureTech Health plc | 144.59 Million USD | -79.181% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -1164.477% |
| IXICO plc | 4.7 Million USD | -5404.355% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -2845.209% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -120.038% |
| CSL Limited | 3.89 Billion USD | 93.345% |
| Cellectis S.A. | 97.32 Million USD | -166.225% |